Overview

Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy

Status:
Withdrawn

Trial end date:
2017-08-24

Target enrollment:

Participant gender:

Summary

RATIONALE: Studying samples of blood in the laboratory from patients receiving radiation therapy and chemotherapy may help doctors learn more about the effects of this treatment on cells. It may also help doctors understand how well patients respond to treatment. PURPOSE: This research study is studying biomarkers in blood samples from young patients with newly diagnosed brain tumors undergoing standard radiation therapy and chemotherapy.

Phase:

N/A

Details

Lead Sponsor:

Pediatric Brain Tumor Consortium

Collaborator:

National Cancer Institute (NCI)